Starkey’s Genesis AI Named a 2024 BOLD Award Finalist

starkey bold award
March 7, 2024

EDEN PRAIRIE, MINNESOTA – Starkey has been named a BOLD Award finalist by the Minnesota Chapter of the Association for Corporate Growth (ACG). Starkey was recognized at the annual gala for its industry-leading Genesis AI hearing aids.

The BOLD Awards honor the innovative and inspirational organizations that make Minnesota great, as well as the teams behind the strategies that led to remarkable performance and accelerated growth.

“This award is the product of a team effort and I want to thank the Starkey family for all of the hard work and dedication that made this possible. This well-deserved recognition helps us continue to raise awareness about hearing healthcare and tear down the stigma associated with hearing loss. Together, we’re helping people not only hear better, but live better.”

–Starkey Chief Hearing Health Officer, Dave Fabry, Ph.D.

When Genesis AI was introduced a year ago, “it marked a new era for Starkey while setting the standard for premium plus technology.”

  • Smallest processor ever by Starkey, but also the most powerful with 6x more transistors.
  • Speed – the Starkey Neuro Processor operates quickly, efficiently, and quietly and is up to 4x faster than previous processors.
  • Less power, more processing – the processor is more efficient with power while delivering significantly higher processing.
  • Loaded with 5X more computational memory and 10X the amount of non-volatile memory.

About Starkey 

Starkey is a privately held, global hearing technology company headquartered in Eden Prairie, Minnesota. Founded by Bill Austin in 1967, Starkey is known for its innovative design, development and distribution of comprehensive digital hearing systems. Led today by President and CEO Brandon Sawalich, Starkey is the only American-owned provider of hearing technologies. The company has more than 5,000 employees, operates 29 facilities and does business in more than 100 markets worldwide.


Source: Starkey

Leave a Reply